Author

Jin Zeng

Observed name: Jin J. Zeng

Institution: GlaxoSmithKline (United States)

Observed institutions: GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States)

OpenAlex ID: A5111593385

Azepanone-Based Inhibitors of Human and Rat Cathepsin K

2001 · Robert W. Marquis, Yu Ru, et al. · Journal of Medicinal Chemistry · 103

Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors

2015 · Hong Lin, Jin Zeng, et al. · ACS Medicinal Chemistry Letters · 89

Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K

2001 · Robert W. Marquis, Yu Ru, et al. · Journal of Medicinal Chemistry · 52

Synthesis and structure–activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors

2012 · Hong Lin, Karl Erhard, et al. · Bioorganic & Medicinal Chemistry Letters · 43

Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors

2012 · Hong Lin, Mark J. Schulz, et al. · ACS Medicinal Chemistry Letters · 39

Azepanone-Based Inhibitors of Human Cathepsin L

2005 · Robert W. Marquis, Ian James, et al. · Journal of Medicinal Chemistry · 25

2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity

2009 · Hong Lin, Dennis S. Yamashita, et al. · Bioorganic & Medicinal Chemistry Letters · 17

Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines

2009 · Hong Lin, Dennis S. Yamashita, et al. · Bioorganic & Medicinal Chemistry Letters · 14

2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles

2009 · Hong Lin, Dennis S. Yamashita, et al. · Bioorganic & Medicinal Chemistry Letters · 13

Works count: 9

Citation count: 395

H-index: 9

I10-index: 9